I am currently reading the book “The billion dollar molecule” based on suggestions from Dr.T, @Teeth and a few others here. Here are a couple of snippets that are interesting.
Amgen’s drug helped doctors increase dosage of SOC to cure a disease much like Bis + Dox. See the potential sales figures, and remember this was in 1991.
Note how Genentech’s failed drug Sales dragged the sector 39% down again showing resemblance to how small cap biotech companies are down after Opthea’s debacle. Also those the commentary that biotechs as a group globally move in lock step - seems to be the case even after 35 years.
I am currently reading the book “The billion dollar molecule”...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.005(0.44%) |
Mkt cap ! $196.3M | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.12 | $202.7K | 178.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22685 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 12644 | 3 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |